Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002)

Diagnostic Microbiology and Infectious Disease - Tập 50 - Trang 59-69 - 2004
Douglas J. Biedenbach1, Gary J. Moet1, Ronald N. Jones1,2
1The JONES Group/JMI Laboratories, North Liberty, IA, USA
2Tufts University School of Medicine, Boston, MA, USA

Tài liệu tham khảo

Beekmann, 2003, Effects of rapid detection of bloodstream infections on length of hospitalization and hospital charges, J Clin Microbiol, 41, 3119, 10.1128/JCM.41.7.3119-3125.2003 Collin, 2001, Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients, Clin Infect Dis, 33, 947, 10.1086/322604 Christensen, 2003, Rapid identification of bacteria from positive blood cultures by terminal restriction fragment length polymorphism profile analysis of the 16S rRNA gene, J Clin Microbiol, 41, 3790, 10.1128/JCM.41.8.3790-3800.2003 Crnich, 2002, The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices, Clin Infect Dis, 34, 1362, 10.1086/340105 Diekema, 1999, Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group, Int J Antimicrob Agents, 13, 257, 10.1016/S0924-8579(99)00131-4 Diekema, 2002, Age-related trends in pathogen frequency and antimicrobial susceptibility of bloodstream isolates in North America, Int J Antimicrob Agents, 20, 412, 10.1016/S0924-8579(02)00204-2 Diekema DJ, Pfaller MA, Schmitz FJ, Smayevsky J, Bell J, Jones RN, Beach M, The SENTRY Participants Group (2001). Survey of infections due to Staphylococcus species: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997–1999. Clin Infect Dis 32, S114 Diekema, 2000, Genetic relatedness of multidrug-resistant, methicillin (oxacillin) resistant Staphylococcus aureus bloodstream isolates from SENTRY antimicrobial resistance surveillance centers worldwide, 1998, Microbiol Drug Resist, 6, 213, 10.1089/mdr.2000.6.213 Karchmer, 2000, Nosocomial bloodstream infections, Clin Infect Dis, 31, S139, 10.1086/314078 Leibovici, 1995, Bacteraemia in the very old, Features and treatment Drugs Aging, 6, 456, 10.2165/00002512-199506060-00005 Leibovici, 2001, Departmental consumption of antibiotic drugs and subsequent resistance, J Antimicrob Chemother, 48, 535, 10.1093/jac/48.4.535 Luzzaro, 2002, Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy, Eur J Clin Microbiol Infect Dis, 21, 849, 10.1007/s10096-002-0837-7 McDougal, 2003, Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States, J Clin Microbiol, 41, 5113, 10.1128/JCM.41.11.5113-5120.2003 Munson, 2003, Detection and treatment of bloodstream infection, J Clin Microbiol, 41, 495, 10.1128/JCM.41.1.495-497.2003 Mutnick, 2003, CANCER resistance surveillance program, Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance. Ann Pharmacother, 37, 47 Mylotte, 2002, Epidemiology of bloodstream infection in nursing home residents, Clin Infect Dis, 35, 1484, 10.1086/344649 National Committee for Clinical Laboratory Standards (2003a). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, sixth edition: Approved standard M7-A6. NCCLS, Wayne, PA National Committee for Clinical Laboratory Standards (2003b). Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S13. NCCLS, Wayne, PA Papanicolaou, 1996, Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients, Clin Infect Dis, 23, 760, 10.1093/clinids/23.4.760 Pfaller, 1998, Bacterial pathogens isolated from patients with bloodstream infection, Antimicrob Agents Chemother, 42, 1762, 10.1128/AAC.42.7.1762 Pfaller, 1999, Survey of bloodstream infections attributable to Gram-positive cocci, Diagn Microbiol Infect Dis, 33, 283, 10.1016/S0732-8893(98)00149-7 Pfaller, 2001, Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program, Clin Infect Dis, 32, S156, 10.1086/320187 Sader, 1999, Bacterial pathogens isolated from patients with bloodstream infections in Latin America, 1997, Brazil J Infect Dis, 3, 97 Sahm, 1999, Antimicrobial resistance in key bloodstream bacterial solates, Clin Infect Dis, 29, 259, 10.1086/520195 Stefani, 2003, Epidemiology of methicillin-resistant staphylococci in Europe, Clin Microbiol Infect, 9, 1179, 10.1111/j.1469-0691.2003.00698.x Velasco, 2003, Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center, Eur J Clin Microbiol Infect Dis, 22, 137, 10.1007/s10096-003-0894-6 Warren, 2001, Nosocomial primary bloodstream infections in intensive care unit patients in a nonteaching community medical center: A 21-month prospective study, Clin Infect Dis, 33, 1329, 10.1086/322483 Weinstein, 1997, The clinical significance of positive blood cultures in the 1990s, Clin Infect Dis, 24, 584, 10.1093/clind/24.4.584 Wisplinghoff, 2003, Nosocomial bloodstream infections in pediatric patients in United States hospitals, Pediatr Infect Dis J, 22, 686, 10.1097/01.inf.0000078159.53132.40 Zaragoza, 2003, The influence of inadequate empirical antimicrobial treatment on patients with bloodstream infections in an intensive care unit, Clin Microbiol Infect, 9, 412, 10.1046/j.1469-0691.2003.00656.x